Clinical Trial: A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment
Study Status: Completed
Recruit Status: Completed
Condition: Renal Impairment
Study Type: Interventional
Official Title: A Phase 1, Open-Label, Single Dose Parallel-Group Study of Brensocatib Following a Single Oral Administration in Subjects With or Without Renal Impairment
Brief Summary:
The primary purpose of the study is to determine the pharmacokinetics (PK) following a single oral dose administration of brensocatib, safety, and tolerability of brensocatib when administered to participants with impaired renal function and in healthy participants.
Read more